Another large biotech IPO has joined the calendar, seeking to buck the trend of mostly negative returns from recent listings in the industry.CARGO Therapeutics (CRGX) launched on Monday, planning to raise $300 million in what would be the year's...read more
After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs...read more
Despite geopolitical turmoil and a major flop from Birkenstock (BIRK) rocking the IPO market last week, a handful of large issuers are lining up to go public. Two sizable IPOs launched on Monday, joined by two notable initial filings....read more
Here's what the top-performing IPOs of 2023 tell us about 2024
Biotechs make up half of the top 10 best-...read more
CAR T cancer biotech CARGO Therapeutics targets a $300 million IPO, as it seeks to overcome weak trading from recent biotech listings
Another large biotech IPO has joined the calendar, seeking to buck the trend of mostly negative returns from recent listings in the industry.CARGO Therapeutics (CRGX) launched on Monday, planning to raise $300 million in what would be the year's...read more
Pessimism over Fed policy and geopolitical tensions topple year's large IPOs; here are the deals that have weathered the recent turmoil
After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs...read more
Large IPOs line up despite latest challenges
Despite geopolitical turmoil and a major flop from Birkenstock (BIRK) rocking the IPO market last week, a handful of large issuers are lining up to go public. Two sizable IPOs launched on Monday, joined by two notable initial filings....read more